Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxisomes | 5 | 2018 | 49 | 1.470 |
Why?
|
| Autophagy | 10 | 2020 | 927 | 1.290 |
Why?
|
| Microtubules | 5 | 2021 | 270 | 1.110 |
Why?
|
| Reading | 1 | 2021 | 81 | 0.750 |
Why?
|
| Reactive Oxygen Species | 6 | 2018 | 987 | 0.730 |
Why?
|
| Histone-Lysine N-Methyltransferase | 5 | 2021 | 461 | 0.700 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 3 | 2016 | 430 | 0.680 |
Why?
|
| Organelles | 1 | 2016 | 40 | 0.550 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2023 | 2326 | 0.470 |
Why?
|
| Dietary Supplements | 2 | 2016 | 558 | 0.470 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 264 | 0.440 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2021 | 1546 | 0.410 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 413 | 0.370 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 3022 | 0.360 |
Why?
|
| Carcinoma, Medullary | 2 | 2023 | 248 | 0.360 |
Why?
|
| Cytoskeleton | 3 | 2021 | 267 | 0.350 |
Why?
|
| Lysine | 4 | 2020 | 422 | 0.350 |
Why?
|
| SMARCB1 Protein | 2 | 2020 | 109 | 0.340 |
Why?
|
| Aurora Kinase A | 2 | 2021 | 202 | 0.340 |
Why?
|
| Proteostasis | 2 | 2019 | 52 | 0.310 |
Why?
|
| Actins | 2 | 2020 | 608 | 0.310 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 287 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 1823 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2021 | 11965 | 0.240 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 2045 | 0.240 |
Why?
|
| Cilia | 2 | 2021 | 92 | 0.230 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 395 | 0.220 |
Why?
|
| Imidazoles | 2 | 2021 | 999 | 0.220 |
Why?
|
| Homeostasis | 2 | 2018 | 950 | 0.200 |
Why?
|
| Methylation | 5 | 2021 | 597 | 0.190 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2021 | 115 | 0.180 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 4821 | 0.180 |
Why?
|
| Tubulin | 2 | 2016 | 169 | 0.170 |
Why?
|
| Animals | 18 | 2021 | 59536 | 0.170 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 321 | 0.170 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 110 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 3552 | 0.160 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 550 | 0.160 |
Why?
|
| Quinolines | 1 | 2021 | 383 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 534 | 0.150 |
Why?
|
| Mitomycin | 2 | 2009 | 208 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 204 | 0.150 |
Why?
|
| Models, Biological | 3 | 2016 | 3254 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2018 | 311 | 0.140 |
Why?
|
| DNA Replication | 1 | 2020 | 744 | 0.140 |
Why?
|
| Histone Code | 1 | 2016 | 79 | 0.140 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 36 | 0.140 |
Why?
|
| Longevity | 1 | 2017 | 154 | 0.130 |
Why?
|
| Chromatin | 1 | 2021 | 942 | 0.130 |
Why?
|
| Biological Assay | 1 | 2016 | 177 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2819 | 0.120 |
Why?
|
| Anxiety | 1 | 2021 | 1179 | 0.120 |
Why?
|
| Mammals | 1 | 2016 | 361 | 0.120 |
Why?
|
| Micronuclei, Chromosome-Defective | 2 | 2018 | 34 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2015 | 3536 | 0.120 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 51 | 0.120 |
Why?
|
| Spermine | 1 | 2013 | 25 | 0.120 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 1960 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2017 | 1129 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 507 | 0.100 |
Why?
|
| Furosemide | 1 | 2011 | 41 | 0.100 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 14551 | 0.100 |
Why?
|
| Cytotoxins | 1 | 2011 | 66 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 591 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2019 | 5710 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2018 | 1682 | 0.100 |
Why?
|
| Mitochondria | 1 | 2018 | 1282 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2287 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2015 | 4804 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 703 | 0.090 |
Why?
|
| Protective Agents | 1 | 2010 | 51 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 741 | 0.090 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2013 | 1643 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 943 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 803 | 0.090 |
Why?
|
| Salicylic Acid | 1 | 2009 | 6 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2013 | 644 | 0.090 |
Why?
|
| Histones | 4 | 2021 | 1466 | 0.090 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2021 | 155 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2011 | 351 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 5637 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1582 | 0.080 |
Why?
|
| DNA Damage | 3 | 2011 | 1954 | 0.080 |
Why?
|
| Mice | 8 | 2021 | 34495 | 0.080 |
Why?
|
| Panax | 1 | 2007 | 33 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2007 | 66 | 0.080 |
Why?
|
| Sirtuins | 1 | 2007 | 44 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1635 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1077 | 0.070 |
Why?
|
| Piperazines | 1 | 2015 | 2101 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 333 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 217 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2007 | 215 | 0.070 |
Why?
|
| Fasting | 1 | 2007 | 349 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 810 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 183 | 0.060 |
Why?
|
| Genomic Instability | 2 | 2018 | 519 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 726 | 0.060 |
Why?
|
| Mitosis | 2 | 2016 | 615 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 4367 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2015 | 265 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 5395 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 3001 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3821 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 10331 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 57 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 82 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2015 | 1489 | 0.050 |
Why?
|
| Carboplatin | 1 | 2023 | 823 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 276 | 0.040 |
Why?
|
| Cell Line | 2 | 2020 | 5114 | 0.040 |
Why?
|
| Comet Assay | 2 | 2009 | 59 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 8873 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 170 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 115 | 0.040 |
Why?
|
| Protein Binding | 2 | 2015 | 3438 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 2009 | 157 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2019 | 231 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2018 | 142 | 0.040 |
Why?
|
| Rats | 3 | 2013 | 6086 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 476 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 294 | 0.040 |
Why?
|
| Cytokinesis | 1 | 2016 | 57 | 0.040 |
Why?
|
| Peroxisome-Targeting Signal 1 Receptor | 1 | 2015 | 3 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2015 | 39 | 0.030 |
Why?
|
| Phagosomes | 1 | 2015 | 72 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 155 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 252 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1987 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2074 | 0.030 |
Why?
|
| Lentivirus | 1 | 2015 | 169 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 600 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 1678 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 388 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2054 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 2063 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 1516 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 663 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 838 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 14289 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 769 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 4307 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 1764 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 1026 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 1408 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 2291 | 0.020 |
Why?
|
| Male | 7 | 2020 | 123000 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 6295 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2009 | 16 | 0.020 |
Why?
|
| Micronucleus Tests | 1 | 2009 | 20 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 703 | 0.020 |
Why?
|
| Reticulocytes | 1 | 2009 | 55 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2009 | 69 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 2738 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 3033 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3639 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 1439 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 448 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2010 | 363 | 0.020 |
Why?
|
| Mutagens | 1 | 2009 | 187 | 0.020 |
Why?
|
| Plant Roots | 1 | 2007 | 45 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 4113 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 6942 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 7226 | 0.020 |
Why?
|
| Antioxidants | 1 | 2010 | 507 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 95 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 15179 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 368 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 257 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 266 | 0.020 |
Why?
|
| Apoptosis | 1 | 2020 | 7591 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2007 | 341 | 0.020 |
Why?
|
| Creatinine | 1 | 2007 | 531 | 0.020 |
Why?
|
| Eating | 1 | 2007 | 421 | 0.020 |
Why?
|
| Neoplasms | 1 | 2010 | 15193 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 848 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 1244 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 2594 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 21713 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 1293 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 1467 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 2146 | 0.010 |
Why?
|
| Liver | 1 | 2009 | 2961 | 0.010 |
Why?
|
| Female | 2 | 2020 | 141928 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 3151 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 7222 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 13658 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 12926 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 77950 | 0.010 |
Why?
|